Artificial intelligence (AI) isn't the only industry with explosive growth potential.

What did the recent study using the crispr gene editing technique actually entail, and what did we learn from it? Hosted by: Hank Green Dooblydoo thanks go to the following Patreon supporters: Kevin ...

If you are trying to work out whether CRISPR Therapeutics is attractively priced or not, starting with the recent share ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the Growth Stock Portfolio: 12 Stock Picks By Cathie Wood. On January 22, 2026, ...

Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...

How CRISPR and functional genomics are used to establish causality, understand disease mechanisms and guide early drug ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

What if a cup of coffee could help treat cancer? Researchers at the Texas A&M Health Institute of Biosciences and Technology ...

In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

Gene-editing citrus fruits to make them less bitter could not only encourage more people to eat them, it might also help save the industry from a devastating plague ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

The hold followed Intellia’s voluntary pause in response to a grade 4 liver event—a case of Hy’s Law—in the ATTR-CM trial.